We have recently demonstrated that miR-155, a miRNA essential to mounting productive pathogen-specific and tumor-specific CD8+ T cell responses15–17, could be harnessed to enhance T cell survival, restrain functional exhaustion, and augment antitumor immunity18. This evidence concerns the gene CD8A and neoplasm.